Moreover, immunofluorescence performed on bladder cancer tissue samples revealed that samples with high IGF2BP2 expression exhibited relatively high levels of CD14 and CD68, consistent with the TCGA‐BLCA and spatial transcriptomics findings (Figure 6D,E). The gene discussed is CD68; the disease is bladder transitional cell carcinoma.